OM:CEVIMedical Equipment
CellaVision (OM:CEVI) Stock Faces Margin Pressure As Net Profitability Undermines Bullish Narratives
CellaVision (OM:CEVI) has posted its Q2 2026 numbers with revenue of SEK199.9 million and net income of SEK32.6 million, translating to basic EPS of SEK1.37 as investors focus on how these figures line up against the company’s recent track record. The company has seen quarterly revenue move from SEK191.3 million in Q2 2025 to SEK199.9 million in Q2 2026, while basic EPS shifted from SEK1.58 to SEK1.37 over the same period. This gives a clear snapshot of how top line and EPS trends are...